[ad_1]
Depends on the treatment of genetic mutations regardless of type or place of origin
The US Food and Drug Administration (FDA) has announced the release of the world's first cancer treatment drug, from its original source, to adults and children, the commissioner said.
Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease, according to Sky News.
"The approval of the authorization and the introduction of this drug is an important step in the treatment of cancer, since it treats it from its source and treats the gene base of cancerous tumors independently from the location of their origin in the human body, "said Commissioner Scott Gottlieb.
Gottlieb has confirmed that the new drug will help cancer patients get proper treatment. Vitracave helps treat people with different cancers but with common genetic mutations.
"Traditionally, cancer has been treated at the root of the cancer source," said Dr. David Hayman, president of the Center for Early Drug Development at the New York Center for Early Drug Development. "Currently, treatment will be done anywhere in the body because you are treating the original gene that caused the tumor," he said.
In reality, the drug has been tested in humans and a child was cured a few months after taking it: the drug will be given to two bodies, the first in the form of tablets or capsules and the other in the form of a children's medicine.
For adults and children .. leave the launch of the "first drug" that treats cancer from its source to the origin
Already electronic newspaper
Previously
2018-11-29
The US Food and Drug Administration (FDA) has announced the release of the world's first cancer treatment drug, from its original source, to adults and children, the commissioner said.
Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease, according to Sky News.
"The approval of the authorization and the introduction of this drug is an important step in the treatment of cancer, since it treats it from its source and treats the gene base of cancerous tumors independently from the location of their origin in the human body, "said Commissioner Scott Gottlieb.
Gottlieb has confirmed that the new drug will help cancer patients get proper treatment. Vitracave helps treat people with different cancers but with common genetic mutations.
"Traditionally, cancer has been treated on the basis of the source of the cancer," said Dr. David Hayman, president of the Center for Early Drug Development at the New York Center for Early Drug Development. "Currently, treatment will be done anywhere in the body because you are treating the original gene that caused the tumor," he said.
In reality, the drug has been tested in humans and a child was cured a few months after taking it: the drug will be given to two bodies, the first in the form of tablets or capsules and the other in the form of a children's medicine.
November 29, 2018
The time now is 08:41 AM
Depends on the treatment of genetic mutations regardless of type or place of origin
The US Food and Drug Administration (FDA) has announced the release of the world's first cancer treatment drug, from its original source, for adults and children, the Commissioner said.
Vitrakvi depends on the treatment of genetic mutations of cancerous tumors, regardless of the type or location of the disease, according to Sky News.
"The approval of the authorization and the introduction of this drug is an important step in the treatment of cancer, since it treats it from its source and treats the gene base of cancerous tumors independently from the location of their origin in the human body, "said Commissioner Scott Gottlieb.
Gottlieb has confirmed that the new drug will help cancer patients get proper treatment. Vitracave helps treat people with different cancers but with common genetic mutations.
"Traditionally, cancer has been treated on the basis of the source of the cancer," said Dr. David Hayman, president of the Center for Early Drug Development at the New York Center for Early Drug Development. "Now the treatment will be done anywhere in the body because you are treating the original gene that caused the tumor," he said.
The drug has actually been tested on humans and a child was cured a few months after taking it: the drug will be given to two bodies, one in the form of tablets or capsules, the other in the form medication for children.
[ad_2]
Source link
